ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 1,054 filers reported holding ASTRAZENECA PLC in Q4 2022. The put-call ratio across all filers is 1.10 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $887,760 | +22.8% | 11,383 | +6.7% | 0.09% | +18.4% |
Q1 2024 | $722,893 | +3.3% | 10,670 | +2.7% | 0.08% | -5.0% |
Q4 2023 | $699,699 | -3.9% | 10,389 | -3.4% | 0.08% | -14.9% |
Q3 2023 | $728,058 | -2.2% | 10,751 | +3.3% | 0.09% | -1.1% |
Q2 2023 | $744,757 | +6.5% | 10,406 | +3.3% | 0.10% | -1.0% |
Q1 2023 | $699,514 | +39.7% | 10,078 | +36.4% | 0.10% | +20.0% |
Q4 2022 | $500,771 | +24.9% | 7,386 | +1.0% | 0.08% | +9.6% |
Q3 2022 | $401,000 | -17.7% | 7,316 | -0.7% | 0.07% | -17.0% |
Q2 2022 | $487,000 | +13.8% | 7,366 | +14.1% | 0.09% | +17.3% |
Q1 2022 | $428,000 | +32.5% | 6,455 | +16.3% | 0.08% | +21.0% |
Q4 2021 | $323,000 | -23.6% | 5,550 | -21.3% | 0.06% | -36.7% |
Q3 2021 | $423,000 | +23.7% | 7,049 | +23.6% | 0.10% | +18.1% |
Q2 2021 | $342,000 | +52.0% | 5,704 | +26.1% | 0.08% | +27.7% |
Q1 2021 | $225,000 | +6.1% | 4,523 | +6.6% | 0.06% | -11.0% |
Q4 2020 | $212,000 | -0.9% | 4,243 | +8.7% | 0.07% | -16.1% |
Q3 2020 | $214,000 | – | 3,905 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
STARR INTERNATIONAL CO INC | 93,000 | $5,586,000 | 11.21% |
Eagle Health Investments LP | 449,565 | $27,001,000 | 8.56% |
SPHERA FUNDS MANAGEMENT LTD. | 1,291,667 | $77,578,000 | 6.52% |
Healthcare Value Capital, LLC | 50,000 | $3,003,000 | 5.93% |
ARDSLEY ADVISORY PARTNERS LP | 500,000 | $30,030,000 | 4.58% |
Asymmetry Capital Management, L.P. | 116,242 | $6,981,000 | 4.20% |
Swaine & Leidel Wealth Services, LLC | 75,880 | $4,557,000 | 4.02% |
Sofinnova Investments, Inc. | 1,128,272 | $67,764,000 | 4.01% |
Eversept Partners, LP | 890,808 | $53,501,928 | 3.71% |
Ruffer LLP | 1,971,796 | $117,064,000 | 3.70% |